Francisco Hidalgo retweeted
Contentos una vez finalizado el OMG XI. 8 casos en vivo, fáciles, difíciles, imposibles,pero con importantes learning points. El éxito gracias a los asistentes. @OjedaOjeda18 @JuradoRomanAl @shci_sec @ignamatsant @Hemodin_LaPaz @pepp183 @AntonioGomezM21 @PCRonline @NievesGonzalo1
2
17
54
2,135
Francisco Hidalgo retweeted
Shock cardiogénico tras parada cardiaca extrahospitalaria: la nueva clasificación SCAI-V añade el lactato a los parámetros hemodinámicos e identifica 4 fenotipos con distinto pronóstico y modo de muerte. Una herramienta para seleccionar mejor al candidato a terapias invasivas. 👇
Following resuscitated out-of-hospital cardiac arrest, cardiogenic shock represents a heterogeneous clinical entity.
The novel SCAI-V classification combines haemodynamic status with lactate to identify four distinct phenotypes associated with mortality and mode of death, sk stratification and patient selection for invasive therapies.
eurointervention.pcronline.com/article/phenot…
#CardiogenicShock
@Pjey90 @drdworakowski @jan_belohlavek @DrNileshPareek @DrKeeble @Jdankiewicz
@MJaguszewski
0
7
21
2,281
A real pleasure to be part of the Colombian Congress of Interventional Cardiology! Excellent organization and outstanding science. I hope I contributed by sharing my experience with IVUS and iFR co-registration. See you soon! 🇨🇴 @PhilipsSpain @shci_sec @mornei2011 @OjedaOjeda18
0
3
8
175
Francisco Hidalgo retweeted
Diseño del estudio LUDICO: eficacia y seguridad del láser coronario en lesiones no dilatables o no cruzables #recintervcardiol @JuradoRomanAl @JonZubiaur @hemodin90 @cardiojsl @FranJHidalgo @NachoGalloFer @belcid7 @BorjaRiversa @Dr_DanielTebar @ari_gonzalvez @RaulmorenoMD @shci_sec recintervcardiol.org/es/articulos-o…
0
7
7
854
Francisco Hidalgo retweeted
In the RAPID-POP RCT (n=607 #STEMI patients), pressure-optimized stent inflation improved reperfusion vs conventional inflation-deflation (WIN ratio 1.42; P=0.004), with less post-dilation & a trend toward lower 30-day #MACE (2.0% vs 4.1%). jacc.org/doi/10.1016/j.… #JACCINT #PCI
6
52
144
29,897
Francisco Hidalgo retweeted
In the double-blind, randomized FITTER trial, 150 patients with acute coronary syndrome and relevant non-culprit lesions received evolocumab or placebo for 12 weeks in addition to high-intensity statin therapy. PCSK9 inhibition did not produce additional short-term improvements , plaque volume, or coronary physiology.
Original article: eurointervention.pcronline.com/article/change…
Editorial: eurointervention.pcronline.com/article/ldquoh…
@hect2701 @RGeuns @NielsRoyen @robebyrne
Original article: eurointervention.pcronline.com/article/change…
Editorial: eurointervention.pcronline.com/article/ldquoh…
@hect2701 @RGeuns @NielsRoyen @robebyrne
1
25
61
9,488
Francisco Hidalgo retweeted
In the randomised BETULA trial, low-dose, short-duration catheter-directed thrombolysis improved early right ventricular unloading compared with anticoagulation alone in patients with intermediate-high-risk pulmonary embolism, without increasing major bleeding. mZ
@Nielsen_Kudsk @Anuburade29
@Nielsen_Kudsk @Anuburade29
1
13
30
4,508
Francisco Hidalgo retweeted
🫀 En @RevEspCardiol — REC Interventional Cardiology: lesión no dilatable ni cruzable, ¿qué hacemos? El ensayo LUDICO evalúa la eficacia y seguridad del láser de excímeros en estas situaciones.
Estudio multicéntrico español.
recintervcardiol.org/es/cardiopatia…
#Hemodinamica
Estudio multicéntrico español.
recintervcardiol.org/es/cardiopatia…
#Hemodinamica
0
2
7
1,815
Francisco Hidalgo retweeted
In a real-world cohort of patients undergoing CTO PCI, a DCB-based strategy, alone or in combination with stents, was associated with favorable 1-y outcomes. No significant differences were observed between DCB-only and blended treatment with a stent jacc.org/doi/10.1016/j.…
0
7
11
713
Francisco Hidalgo retweeted
Enhorabuena a @OjedaOjeda18 por su nombramiento como Jefa de Sección de nuestra UGC. Todo un orgullo para el servicio contar con tu liderazgo para seguir ofreciendo la mejor asistencia a nuestros pacientes. ¡A por nuevos retos! 🚀 @HUReinaSofia @MPAOSS
10
20
53
6,318
Francisco Hidalgo retweeted
Does timing of ventricular unloading matter in STEMI-related cardiogenic shock?
New registry data and an accompanying Editorial explore whether "door-to-unload" may emerge as an important metric in shock care.
👉Original Article eurointervention.pcronline.com/article/door-t…
👉Editorial x
#CardiogenicShock #STEMI #MechanicalCirculatorySupport #InterventionalCardiology
@BenediktSchrage
New registry data and an accompanying Editorial explore whether "door-to-unload" may emerge as an important metric in shock care.
👉Original Article eurointervention.pcronline.com/article/door-t…
👉Editorial x
#CardiogenicShock #STEMI #MechanicalCirculatorySupport #InterventionalCardiology
@BenediktSchrage
1
18
42
5,540
Francisco Hidalgo retweeted
Aortic Valve Leaflet Modification: A Working Group Position Statement on Best Practices and Step-by-Step Guide
-> Coronary obstruction during TAVR is rare, catastrophic, and predictable by CT.
-> AVLM prevents coronary obstruction in high-risk anatomies.
jacc.org/doi/10.1016/j.…
-> Coronary obstruction during TAVR is rare, catastrophic, and predictable by CT.
-> AVLM prevents coronary obstruction in high-risk anatomies.
jacc.org/doi/10.1016/j.…
0
7
22
1,466
Francisco Hidalgo retweeted
In STEMI complicated by cardiogenic shock, timing may extend beyond reperfusion alone. In this nationwide registry, earlier left ventricular unloading with a microaxial flow pump was associated with lower in-hospital mortality, suggesting that "door-to-unload" time may emerge as shock care.
🔗eurointervention.pcronline.com/article/door-t…
#STEMI #CardiogenicShock #Impella
🔗eurointervention.pcronline.com/article/door-t…
#STEMI #CardiogenicShock #Impella
1
23
56
3,216
Save the date!
Join the first Philips live webinar for Latin America & Spain, moderated by Dr. Zajarías.
Coronary physiology, iFR, SyncVision, co-registration, and practical case-based learning.
#InterventionalCardiology #CoronaryPhysiology #iFR #CoRegistration
Join the first Philips live webinar for Latin America & Spain, moderated by Dr. Zajarías.
Coronary physiology, iFR, SyncVision, co-registration, and practical case-based learning.
#InterventionalCardiology #CoronaryPhysiology #iFR #CoRegistration
1
5
10
437
Francisco Hidalgo retweeted
🫀 Mesa "Cardiacos Agudos" en el #59CongresoSAC.
Soporte en arritmias complejas, manejo del paciente cardiovascular agudo y el debate sobre Impella en shock cardiogénico post-IAM.
Sin consenso fácil.
#SAC26 #cardiologíaaguda #cardiología
Soporte en arritmias complejas, manejo del paciente cardiovascular agudo y el debate sobre Impella en shock cardiogénico post-IAM.
Sin consenso fácil.
#SAC26 #cardiologíaaguda #cardiología
2
6
10
804
Francisco Hidalgo retweeted
Arranca el Taller Complex PCI en el #59CongresoSAC.
IVUS, Rotapro, Wolverine. Fellows del Grupo de Trabajo de Hemodinámica de la SAC, manos a la obra.
#SAC26 #hemodinámica #cardiología
IVUS, Rotapro, Wolverine. Fellows del Grupo de Trabajo de Hemodinámica de la SAC, manos a la obra.
#SAC26 #hemodinámica #cardiología
0
11
22
1,466
Francisco Hidalgo retweeted
💥#CasoClínicoMercé73
➡️ "IAMCEST inferior de etiología embólica" presentado por el Dr. Francisco Hidalgo del @HUReinaSofia.
🩺“Cuando una buena aspiración es mejor que cualquier otra manipulación del trombo”.
📄▶️ mercev.com/caso-clinico-n…
#IAMCEST #CardiologiaIntervencionista
➡️ "IAMCEST inferior de etiología embólica" presentado por el Dr. Francisco Hidalgo del @HUReinaSofia.
🩺“Cuando una buena aspiración es mejor que cualquier otra manipulación del trombo”.
📄▶️ mercev.com/caso-clinico-n…
#IAMCEST #CardiologiaIntervencionista
0
1
2
162
Francisco Hidalgo retweeted
First case in Spain completed with Intrasight Plus. @OjedaOjeda18 @belcid7 @shci_sec @Monicaferqu @JuradoRomanAl @secardiologia @FranJHidalgo @rafaelglezm @cardiojsl @srdeleiras @pepp183 @ignamatsant @GomezMenchero @MesaLola @AntonSoleRovira @PCRonline @mornei2011 @NachoGalloFer
2
13
35
3,570










































